
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy p. 912 - 918 (2006)
Update date:2022-08-04
Topics:
Wu, Wei-Na
Yuan, Wen-Bing
Tang, Ning
Yang, Ru-Dong
Yan, Lan
Xu, Zi-Hua
Three new aryl amide type ligands, N-(phenyl)-2-(quinolin-8-yloxy)acetamide (L1), N-(benzyl)-2-(quinolin-8-yloxy)acetamide (L2) and N-(naphthalene-1-yl)-2-(quinolin-8-yloxy)acetamide (L3) were synthesized. With these ligands, three series of lanthanide(III) complexes were prepared: [Ln(L1)2(NO3)2]NO3, [Ln(L2)2(NO3)2(H2O)2]NO3·H2O and [Ln(L3)2(NO3)2(H2O)2]NO3·H2O (Ln = La, Sm, Eu, Gd). The complexes were characterized by the elemental analyses, molar conductivity, 1H NMR spectra, IR spectra and TG-DTA. The fluorescence properties of complexes in the solid state and the triplet state energies of the ligands were studied in detail, respectively. It was found that the Eu(III) complexes have bright red fluorescence in solid state. The energies of excited triplet state for the three ligands are 20 325 cm-1 (L3), 21 053 cm-1 (L2) and 22 831 cm-1 (L1), respectively. All the three ligands sensitize Eu(III) strongly and the order of the emission intensity for the Eu(III) complexes with the three ligands is L3 > L2 > L1. It can be explained by the relative energy gap between the lowest triplet energy level of the ligand (T) and 5D1 of Eu(III). This means that the triplet energy level of the ligand is the chief factor, which dominates Eu(III) complexes luminescence.
View MoreShenzhen ZheYi Chemicals Co.,LTD(Shanghai Branch)
Contact:+86-21-54159691
Address:Room1002,Building No.2, Lane 98 Bixiu Road,Minhang District, Shanghai,China 201100
Binzhou Holly Pharmaceutical Co.,Ltd.
Contact:74517
Address:No.15 Dapu Road,Huangpu District Shanghai,P.R.China
Shandong Jiulong Hisince Pharmaceutical Co.,Ltd.
Contact:--
Address:Huadian Pioneer Park, Huadian Township, Qihe County, Dezhou City, Shandong, P.R.China
Contact:91 Area80 9844218056
Address:
Chengdu Cogon Bio-tech Co., Ltd.
Contact:86-28-85171192
Address:NO.52.YongFeng Rd. Chengdu,610041,P.R.China.
Doi:10.1016/S0040-4020(01)96030-2
(1991)Doi:10.1007/s11172-006-0092-7
(2005)Doi:10.1021/ol0624023
(2006)Doi:10.1021/ol062126s
(2006)Doi:10.1016/j.bmc.2006.07.055
(2006)Doi:10.1002/adsc.200900621
(2009)